Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlethora Solutions Holdings Plc Share News (PLE)

  • There is currently no data for PLE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Regent Pacific To Acquire Plethora Solutions For GBP114.3 Million

Tue, 15th Dec 2015 13:47

LONDON (Alliance News) - Regent Pacific Group Ltd on Tuesday said it has agreed to acquire the shares it doesn't already own in Plethora Solutions Holdings PLC, valuing the premature ejaculation treatment company at 11.65 pence per share.

The deal values Plethora at about GBP95.9 million, based on the number of shares in issue, and at GBP114.3 million when considering its fully diluted share capital. Shareholders in Plethora will receive 15.7076 new Regent Pacific shares for each Plethora share they own. Shares in Plethora jumped by 18% to 5.30p on Tuesday afternoon.

The deal comes about six weeks after the companies said they had agreed on the key terms of a possible deal.

James Mellon is the non-executive chairman of Plethora and non-executive co-chairman of Regent Pacific, and Jamie Gibson is an executive director and the chief executive of both companies. Plethora's main product is PSD502, a treatment for premature ejaculation.

On completion of the offer, Plethora shareholders other than Regent Pacific will own about 65.98% of the combined group.

"This offer is about optimising growth and realising the potential of an innovative product that can address a known medical condition affecting almost one in four men. With increased investment and commercial innovation, we see huge scope for the product initially in Europe where it has approval, and in the important US market and in the fast growing Asian market in due course," James Mellon said.

"We view the offer as taking account of PSD502TM's prospects, while also providing a compelling premium of more than 38% to the price at which Plethora's last issued shares in August 2014 and we believe it will create significantly more future value than Plethora could achieve independently," Mellon added.

Michael Wyllie, chief science officer at Plethora, said the deal presents an "achievable solution to its difficult financial position whilst providing shareholders an opportunity to maintain an ongoing economic interest in Plethora and its product".

By Samuel Agini; samagini@alliancenews.com; @samuelagini

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
12 Mar 2014 09:03

Wednesday broker round-up UPDATE

Ashtead Group: Citi raises target price from 850p to 1075p keeping a buy recommendation. Barratt Developments: Goldman Sachs reduces target price from 527p to 502p and downgrades to neutral. British Land: Jefferies downgrades to hold with a target price of 707p. Brooks Macdonald Group: Canaccord

Read more
11 Mar 2014 14:16

UK MIDDAY BRIEFING: African Barrick Gold Hit By Stake Sale

LONDON (Alliance News) - African Barrick Gold has fallen sharply Tuesday after parent Barrick Gold Corp sold a 10% stake, while Sports Direct International is up after the company's board said it will again try and give Mike Ashley a bigger stake as payment fo

Read more
11 Mar 2014 13:51

CORRECT: UK WINNERS & LOSERS: African Barrick Gold Leads FTSE 250 Fallers

(An item published at 1145 GMT mistated the year-earlier period in the Fenner summary and the revenue figures in the Inchcape summary. The correct version follows:) LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Tues

Read more
11 Mar 2014 11:45

UK WINNERS & LOSERS: African Barrick Gold Leads FTSE 250 Fallers

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Tuesday.

-------

FTSE 100 - WINNERS

Sports Direct International, up 2.5%. The sports goods retailer said it

Read more
11 Mar 2014 10:20

Plethora soars on drug development update

Plethora Solutionas saw its value jump by around a third on Tuesday morning after it revealed a meeting with the US Food and Drug Administration (FDA) had resulted in a clear pathway to the successful submission of a new drug application. The application is for PSD 502, a drug used in the treatmen

Read more
11 Mar 2014 09:47

Plethora Solutions Shares Jump 33% As It Moves Ahead With PSD 502

LONDON (Alliance News) - Shares in Plethora Solutions Holdings PLC jumped 33% Tuesday morning after it said it was in negotiations with a number of potential marketing partners for its premature ejaculation treatment PSD 502. The company said following its meeting with the US Food and Drug

Read more
3 Feb 2014 09:20

Plethora Solutions Mulls Dosage Change That Could Raise Profit Potential

LONDON (Alliance News) - Plethora Solutions PLC Monday said it is considering reducing the size of the doses of its premature ejaculation treatment that it eventually brings to market, potentially increasing the profits it can make, as it also said it had a positive initial meeting with US regula

Read more
28 Nov 2013 12:27

CORRECT: AIM IN BRIEF: Herstal Emerges As Favourite To Acquire Manroy

Read more
28 Nov 2013 11:41

Plethora Solutions Slides As CEO Unexpectedly Departs

Read more
28 Nov 2013 08:22

AIM IN BRIEF: Beretta Emerges As Favourite To Acquire Manroy

Read more
22 Nov 2013 12:13

STOCKS NEWS EUROPE-UK small caps up 0.2 pct at mid-session

The FTSE small cap index is up 0.2 percent into mid-session and junior-listed AIM shares gain 0.3 percent, both outperforming a 0.2 percent fall on the blue chips. Shares in AIM-listed investment company Clear Leisure more than double in price to 2.61 pence in heavy volumes after receiving

Read more
22 Nov 2013 09:17

Plethora Solutions Talking With Several Parties About Sales Of Its Treatment

Read more
22 Nov 2013 07:40

AIM IN BRIEF: IMIC Share Placing Raises GBP13.0 Million

Read more
19 Nov 2013 12:28

UK WINNERS & LOSERS: Travel Stocks Take Off; Afren, Lekoil Lifted By Nigeria Find

Read more
19 Nov 2013 10:49

Plethora Gets European Marketing Approval For Ejaculation Treatment

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.